Pular para o conteúdo principal
  • Parceiros aprovados
  • Sobre a ELGA
    • Sobre a ELGA
    • Carreiras
    • Eventos
  • Apoio
    • Planeamento laboratorial
    • Registar um produto
    • Register Your Product (USA & Canada Only)
  • Contacto
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • 日本
  • 中国
Início ELGA LabWater
  • Produtos
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • Gama completa dos produtos ELGA
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
    • Estudos de caso
    • Água ultrapura
    • Guias e Livros brancos
  • Produtos
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • Gama completa dos produtos ELGA
      • PURELAB® Classic
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Knowledge
    • Blogue
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • Estudos de caso
      • A Abbott Diagnostics escolhe os sistemas ELGA MEDICA no Sul da Ásia
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA: a maior empresa de diagnósticos médicos do Brasil
      • A ELGA ajuda os laboratórios de imunosserologia a maximizar o tempo de atividade
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • Importância da água ultrapura Tipo 1+ para o desenvolvimento de medicamentos genéricos
      • MEDICA® Pro selecionado para analisadores Siemens ADVIA® no City General Hospital
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex: um sistema de formação ideal para o método de investigação atual
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • Desvendar os segredos da Antártida com a ajuda de água ultrapura
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • Água ultrapura
    • Guias e Livros brancos
      • Pureza da água de HPLC
      • HPLC no setor farmacêutico
      • Redução de riscos clínicos
      • Sustentabilidade
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • 日本
  • 中国
  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
  • Início
  • Exploring The Origins Of Childhood Leukaemia
Analytical Chemistry
Science of the Future

Exploring The Origins Of Childhood Leukaemia

29 mar 2020
- by Dr Alison Halliday

Child with Cancer

Researchers analyse archived newborn blood spots to look for exposures in the womb that may affect the risk of developing the most common childhood cancer.


Recent evidence suggests that childhood leukaemia involves at least two events – the first occurring when the baby is developing in the womb, with a second following after their birth. Although the precise factors that contribute to these events are not fully understood, the rising incidence of childhood leukaemia over time, particularly in affluent countries, suggests that environmental and lifestyle factors are involved.

Both the developing fetus and child are exposed to a multitude of potentially harmful chemicals – such as those generated from intrinsic metabolic processes or from exogenous sources including infections, diet or parental smoking.

Although many of these chemicals are stable molecules that can be measured with techniques such as metabolomics or proteomics, others are metabolised into electrophilic compounds that can alter physiological processes in early life but can’t be measured in the body. This makes it challenging for researchers to investigate their potential impact on the risk of developing a disease later in life.

A Proxy Marker In Newborn Blood Spots

The Cys34 residue of the most abundant blood protein, human serum albumin (HSA), is a powerful scavenger of electrophilic compounds. As its turnover in the body is 28 days, measuring the modifications (adducts) of this amino acid in archived newborn blood spots offers an indirect way to capture fetal exposures during the last month of pregnancy. 

In a new study, published in Leukemia Research, a team of researchers analysed these Cys34 adducts in the HSA protein in archived newborn blood spots as a way obtain new information about exposures in the womb and investigate how these may impact on the risk of childhood leukaemia.1 

The team used an adapted untargeted adductomics method based on nanoflow liquid chromatography-high resolution mass spectrometry (nLC-HRMS) to characterise Cys34 adducts in the archived newborn blood spots. They used ultrapure water from an ELGA PURELAB® laboratory water purification system to minimise the risk of introducing contaminants that may affect the results of this sensitive analytical technique.

Comparing Abundances In Cases And Controls

The researchers analysed 782 archived newborn blood spots collected from participants of the California Childhood Leukaemia Study (CCLS) – including 338 children with acute lymphoblastic leukaemia (ALL), 45 with acute myeloid leukaemia (AML) and matched healthy controls.

While they identified no clear associations between adduct abundance with either childhood leukaemia or ALL overall, they did identify differences between samples from children with subtypes of the disease and healthy controls – albeit in small sample sizes.

Children with T-cell ALL had higher abundances of adducts of reactive carbonyl species. And interestingly, there was a 44% decrease in abundances of a homocysteine adduct in AML cases.

Preventing Childhood Leukaemia

Although the results shed light on potential exposures involved in the development of certain subtypes of ALL before birth, larger studies are now needed to confirm these findings and further explore their implications.

As there are very few known lifestyle-related or environmental causes of childhood leukaemias, identifying modifiable risk factors could lead to new ways to help reduce the risk of the disease.

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.


Reference:

  1. Yano, Y. et al. Untargeted Adductomics of Newborn Dried Blood Spots Identifies Modifications to Human Serum Albumin Associated with Childhood Leukaemia. Leukemia Research 2019; S0145-2126(19)30713-1.


Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

  • Enquiry
  • Obter uma cotação
  • Agende uma demonstração
  • Encontre um parceiro aprovado

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Obter uma cotação

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Agende uma demonstração

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Headquarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Sede da ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Estudos de caso

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Recursos

  • Saber mais sobre água ultrapura
  • Guias e Livros Brancos
  • Tecnologias de purificação
  • Aplicações
  • Impurezas na água

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Outros sítios Web da Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies

© VWS (UK) Ltd. negociando como ELGA LabWater.2022-Todos os direitos reservados.
ELGA é a marca global de água para laboratórios da Veolia.

  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Impressum
Elga Veolia
TOP

© 2017 ELGA Veolia